NSE filing, NSE: VIYASH. Summary written from the filing by ALFA Finder's alert engine.
Viyash Scientific Ltd: key numbers
- Share price
- ₹227.00
- Market cap
- ₹10,028 Cr
- Revenue (annual)
- ₹3,420 Cr
- Net profit (annual)
- ₹177.3 Cr
- P/E (TTM)
- 58.6×Sector 46.1×
- Promoter holding
- 49.24%-12.07% QoQ
- FII holding
- 2.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Viyash Scientific Ltd
All →Viyash Scientific Management Change
Viyash Scientific Limited has appointed Dr. Mallikharjuna Rao Nagineni as Senior Vice President, Human Resources, succeeding the retiring Mr. Prasad Lad.
Viyash Scientific Capital Structure Change
White Oak Capital Management Consultants LLP disclosed the sale of 8,747,392 equity shares of Viyash Scientific Ltd, reducing its stake in the open market.
Viyash Scientific Other Announcement
Viyash Scientific Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31.
Viyash Scientific Employee Stock Options
Viyash Scientific allotted 1,35,880 ESOP shares at exercise prices of Rs. 86 and Rs. 101. The allotment reflects employee stock option exercises under two active schemes.
Viyash Scientific Acquisition Worth ₹193.4 Cr
Viyash Scientific's subsidiary completed the acquisition of BioForLife Italia s.r.l. for a total consideration of Rs.193.41 Crore. This transaction was previously announced in June.
- Value
- ₹193.4 Cr
Viyash Scientific Acquisition Worth ₹18.33 Cr
Viyash Scientific's subsidiary completed the acquisition of Italy-based BioForLife Italia S.r.l. for a total consideration of approximately EUR 16.98 million.
- Value
- ₹18.33 Cr
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.